Artelo Biosciences Inc.

ARTL | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.15

+$0.05 (+1.22%)

At close: Sep 22, 2026, 4:00 PM ET

$4.11

-$0.04 (-0.94%)

After-hours: Sep 22, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.22%

(1D)

Rating

Updated: Aug 26, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.61M

1D Range

3.86 4.20

52W Range

3.45 179.19

Valuation (TTM)

PE -0.50

PB 0.32

EV/EBITDA 0.21

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -795.6%

SBC Adj. FCF Yield -907.1%

SBC Impact -14.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -53.5% | -51.5%

FCF 3Y | 5Y -17.7% | -9.4%

Returns

ROA -196.2%

ROE -519.1%

ROIC -219.4%

Financial Health

Net Cash

$4.15M

Current Ratio 3.00

Interest Coverage -17.91

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust deve...

Sector Healthcare

Industry Biotechnology

Employees 7

IPO Date Jun 20, 2019

Website www.artelobio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Buy (0)

Hold (1)

Sell (0)

Analyst Details ➞